Pledge giggles himself silly as he shoves the CYP chart at us ... and bedger slaps him with the MSB chart in response (adding another intelligent rebuttal of the time-wasting clown, as many other great posters are doing. Cheers!).
Both charts show that a rough start for global stock markets has made for some particularly hot EOFY sales. Seems the time to get in and buy up more of the gem stocks. With MSB and CYP both at bargain prices - MSB can keep what they've got on offer; I'm riding with CYP for their big pops to come. aGvHD in adults is going to be big and Osteoarthritis even bigger! So, I got in yesterday and topped up.
For those thinking through their own EOFY buy-ins, our CEO's latest interview is solid food for thought. If you missed the link WilliInvest1970 posted, here it is again.
Kilian runs through the goals and timing of significant inflection points in the lead up to our much anticipated, double-bang of results by early '26. With the intensive scientific advancement the team has already achieved for CYP, it's a damned fine line-up; more than enough to spur on the desperate efforts of the MSB trolls to bog down our threads.
CYP Price at posting:
17.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)